Thomas Hancock

A&G Pharmaceutical, Inc. develops and creates monoclonal antibodies to cancer-specific targets. It focuses on a near-term opportunity to complete development of and commercialize two GP88-based breast cancer diagnostic test kits to improve early detection, diagnosis and treatment of breast cancer. The firm's product Theranostics develops molecular diagnostic tests in tandem with targeted therapeutics. The company was founded by Jun Hayashi, Ginette Serrero, and Gordon H. Sato in June 2000 and is headquartered in Columbia, MD.

Nexus Medical LLC(Nexus Medical) is a Venture Capital firm founded in 1996 by Edwin Snape and John F. Rousseau. The firm is headquartered in Quincy, Massachusetts.

Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA.

Spectra Analysis Instruments, Inc. supplies molecular spectroscopy systems and applications for chromatography. The company was founded by George J. Giansanti, William W. Carson and Sydney Bourne in 1993 and is headquartered in Marlborough, MA.

Magellan Biosciences, Inc. engages in the manufacture of medical devices for point-of-care systems, clinical laboratory instruments, and analytical laboratory. The company was founded on May 4, 2005 and is headquartered in North Billerica, MA.

Stheno Corp. develops non contact chemical detectors and detection systems for the pharmaceutical industry. The firm commercializes a chemical-detection technology to find impurities in pharmaceutical processing and production line. The company was founded by Phillip R. Gibbs and William Edens on June 24, 2003 and is headquartered in Atlanta, GA.

The Company's principal activity is to identify a manufacturing or distributing products or specialty materials business to, or provides services within, the healthcare sector, as well as other sectors within the experience and competencies of the management team. Its product may includes medical devices used in cardiovascular, orthopedic, gynecological, urological, metabolic disease and neurovascular applications, medical devices used in drug delivery, vitro and in vivo diagnostic testing equipment and reagents,analytical instruments and related consumables used in drug development, imaging equipment and contrast agents and information technology applications.

Piper Sandler & Co. (Broker) (PSC-Broker) is the full-service brokerage division of Piper Sandler & Co., a financial service firm headquartered in Minneapolis, Minnesota. They are a subsidiary of Piper Sandler Companies (NYSE: PIPR). The firm was founded in 1969 and previously known as Piper Jaffray & Co. They became Piper Sandler & Co. when Piper Jaffray Companies and Sandler O’Neill & Partners, L.P. merged to become Piper Sandler Companies in 2020. PSC-Broker provides brokerage and investment banking services to financial institutions, corporations and other financial investors. Their core focus sectors are Agriculture, renewables & cannabis, Business services, Chemicals & Materials, Consumer, Diversified industrials & services, Energy, Financial services, financial sponsors, Healthcare, and Technology.